Head-to-head · WeighScore
NP2GO vs Science & Co
The verdict
NP2GO takes it — 80.2/100 to 72.9/100.
NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | NP2GO | Science & Co |
|---|---|---|
| WeighScore | 80.2/100 | 72.9/100 |
| Grade | B− | C |
| Scorecard rank | #37 | #86 |
| Semaglutide | $150/mo | $149/mo month-to-month ($79 only on a 12-month plan) |
| Tirzepatide | $250/mo | $199/mo month-to-month ($125 only on a 12-month plan) |
| Coverage | 40 states | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #37 · B−
Strengths
- Both molecules
- 40-state footprint
- Transparent listed pricing
Where it loses points
- Not LegitScript-verified
- Upper-mid pricing ($150/$250)
- Not all 50 states
Graded #86 · C
Strengths
- States twice in its footer that "Science and Co, Inc. is not a 503A or 503B compounding facility"
- Its own FAQ names the commitment behind the headline: "Plans start at $125 a month on the 12 month plan"
- The printed saving corroborates the reference price — 125 divided by 199 is 63%, exactly the "Save 37%" shown
- "Same Price, Any Dose", with no hidden fees, no monthly membership and free shipping stated in the FAQ
- Names its operating entity and state of incorporation, and says every batch is third-party tested
Where it loses points
- The number it leads with is a twelve-month commitment; the per-month rates are $149 and $199
- Only two figures are published per drug, so a three- or six-month plan cannot be priced without starting an intake
- It says it is not a compounding facility but never names the pharmacy that is
- No lab or monitoring protocol is published
- Injection only on the pages read — no oral route and no brand lane
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.